Qube Research & Technologies (QRT)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.8M | Buy |
670,117
+446,487
| +200% | +$31.2M | 0.05% | 342 |
|
|
2025
Q1 | $16.4M | Sell |
223,630
-366,911
| -62% | -$27M | 0.02% | 624 |
|
|
2024
Q4 | $38.7M | Sell |
590,541
-312,871
| -35% | -$20.5M | 0.05% | 354 |
|
|
2024
Q3 | $70.4M | Buy |
903,412
+876,708
| +3,283% | +$68.3M | 0.1% | 189 |
|
|
2024
Q2 | $2.08M | Sell |
26,704
-60,877
| -70% | -$4.75M | ﹤0.01% | 1344 |
|
|
2024
Q1 | $5.93M | Sell |
87,581
-879,473
| -91% | -$59.6M | 0.01% | 965 |
|
|
2023
Q4 | $65.1M | Buy |
967,054
+895,598
| +1,253% | +$60.3M | 0.13% | 186 |
|
|
2023
Q3 | $4.84M | Sell |
71,456
-502,413
| -88% | -$34M | 0.01% | 745 |
|
|
2023
Q2 | $41.1M | Buy |
573,869
+74,189
| +15% | +$5.31M | 0.15% | 185 |
|
|
2023
Q1 | $34.7M | Buy |
499,680
+17,785
| +4% | +$1.23M | 0.15% | 144 |
|
|
2022
Q4 | $32.7M | Buy |
481,895
+126,671
| +36% | +$8.59M | 0.17% | 134 |
|
|
2022
Q3 | $19.5M | Buy |
+355,224
| New | +$19.5M | 0.12% | 230 |
|
|
2020
Q4 | – | Sell |
-107,150
| Closed | -$5.87M | – | 1798 |
|
|
2020
Q3 | $5.87M | Sell |
107,150
-7,896
| -7% | -$433K | 0.08% | 306 |
|
|
2020
Q2 | $6.09M | Buy |
+115,046
| New | +$6.09M | 0.09% | 286 |
|
|
2020
Q1 | – | Sell |
-50,278
| Closed | -$2.51M | – | 1128 |
|
|
2019
Q4 | $2.51M | Buy |
50,278
+35,719
| +245% | +$1.78M | 0.08% | 301 |
|
|
2019
Q3 | $649K | Buy |
+14,559
| New | +$649K | 0.43% | 68 |
|
|
2018
Q2 | – | Sell |
-7,188
| Closed | -$251K | – | 834 |
|
|
2018
Q1 | $251K | Buy |
+7,188
| New | +$251K | 0.1% | 132 |
|